Objectives: Nupharidine (6,6′-Dihydroxythiobinupharidine), purified from the aquatic plant Nuphar lutea leaves (Water lily) prompts antimicrobial activity of immune cells.
| INTRODUC TI ON
Neutrophils play a crucial role in the clearance of pathogens, by various effector functions such as phagocytosis, degranulation and formation of neutrophil extracellular traps (NETs) (Scott & Krauss, 2012) . Periodontitis in adolescents and young adults (formerly Aggressive Periodontitis) is associated with specific infection by Aggregatibacter actinomycetemcomitans, JP2 clone (Aa-JP2) (Haubek et al., 2008) and also with abnormal neutrophil function (DeNardin, DeLuca, Levine, & Genco, 1990; Scott & Krauss, 2012; Shapira, Borinski, Sela, & Soskolne, 1991; Sigusch, Eick, Pfister, Klinger, & Glockmann, 2001; Suzuki, Collison, Falkler, & Nauman, 1984) . Classical studies have demonstrated that in this variant of periodontitis, neutrophils have impaired chemotaxis (DeNardin et al., 1990; Sigusch et al., 2001) , defective phagocytosis (Suzuki et al., 1984) and increased superoxide production (Shapira et al., 1991) . These impaired functions may explain why the host is unable to effectively resolve Aa-JP2 infection. Further, Aa-JP2 holds powerful virulence factors, such as the exotoxins, cytolethal distending toxin and leukotoxin A, of which the later causes neutrophils death via necrosis and evasion from phagocytosis (Claesson, Johansson, Belibasakis, Hanstrom, & Kalfas, 2002; Johansson, Sandstrom, Claesson, Hanstrom, & Kalfas, 2000) .
Clinical treatment of Aa-JP2 periodontitis has historically proved to be challenging due to the fact that depletion of this keystone pathogen is poorly achieved by non-surgical treatments.
Consequently, concomitant use of antibiotics or surgical debridement is included to improve treatment outcomes [3] . This clinical reality prompts the search of new strategies to treat the disease.
Furthermore, a great concern over bacterial antibiotic resistance supports the development of alternative treatment modalities excluding antibiotic regimens.
Unlike standard treatment modalities, emerging data reveal the potential of unconventional medicine for managing infectious disease. Such modalities are based on various plant extracts, phytochemical compounds and essential oils. In the periodontal field, the use of natural products has scarcely been investigated.
Such studies showed various biological effects mainly on bacterial physiology. Vaccinium macrocarpon (Ericaceae) fruit (cranberry) is one of the most studied antibacterial adhesion herbs. Flavonoids and proanthocyanidins isolated from fresh cranberry fruit were found to inhibit growth and biofilm formation of Porphyromonas gingivalis (Feghali, Feldman, La, Santos, & Grenier, 2012; Polak, Naddaf, Shapira, Weiss, & Houri-Haddad, 2013) . Camellia sinensis (Theaceae) is another natural product originating in China. Green tea made from C. sinensis, and its polyphenols potently blocked in vitro the adhesion of P. gingivalis and have been shown to inhibit dental plaque accumulation (Sakanaka, Aizawa, Kim, & Yamamoto, 1996) . Kaempferia pandurata Roxb. (Zingiberaceae), known as temu kunci in Indonesia, has been used traditionally for food and medicinal purposes, and its bioactive components-Panduratin A and isopanduratin A-exhibit strong activities against cariogenic pathogens and periodontal pathogens, especially Prevotella intermedia and P. gingivalis (Yanti, Rukayadi, Lee, & Hwang, 2009) .
Eugenia caryophyllata L. (Myrtaceae) extract is another widely used natural product and is active against oral bacteria associated with periodontal disease (Cai & Wu, 1996) as well as a large number of other pathogenic bacteria (Chaieb et al., 2007) . Other active constituents of clove (biflorin, kaempferol, rhamnocitrin, myricetin, gallic acid, ellagic acid and oleanoic acid) showed antibacterial activities against Gram-negative anaerobic periodontal oral pathogens, including P. gingivalis and P. intermedia (Cai & Wu, 1996) . The Eucalyptus (Myrtaceae) tree extracts were shown to have specific activity against periodontal bacteria, such as P. gingivalis, A. actinomycetemcomitans and Fusobacterium nucleatum (Takarada et al., 2004) .
Several plant organs of Nuphar lutea (Yellow Water Lilly) are used in traditional medicine for the treatment of arthritis, fever, aches, pains and inflammation . We showed that semi-purified extracts of Nuphar lutea containing active thio-sesquiterpene molecules, Nupharidine (6,6′-Dihydroxythiob inupharidine), have anti-cancer and pro-apoptotic activity (Ozer, Fishman, Eilam, Golan-Goldhirsh, & Gopas, 2017; Ozer et al., 2009) , as well as anti-inflammatory (Ozer, Levi, Golan-Goldhirsh, & Gopas, 2015) and modulatory effects on NF-κB ). In addition, it has anti-leishmanial activity (El-On, Ozer, Gopas, Sneir, & Golan-Goldhirsh, 2009 ) and increased iNOS production by macrophages, against Leishmania major (Ozer, El-On, Golan-Goldhirsh, & Gopas, 2010) . Nupharidine was also shown to have antimicrobial properties against multidrug-resistant bacteria (Okamura et al., 2015) .
The current study investigated the in vitro antimicrobial capability of Nupharidine against A. actinomycetemcomitans JP2 and its effect on neutrophils. The effect of Nupharidine was determined on HL-60 derived neutrophils, and human peripheral blood neutrophils derived from young patients with periodontitis and periodontally healthy volunteers.
| MATERIAL S AND ME THODS

| Neutrophil-like cells
Neutrophil-like cells were differentiated from the HL-60 cell line) ATCC; Manassas, VA, USA(, with 1.3% dimethyl sulfoxide (DMSO) for 4 days as detailed by Collins, Ruscetti, Gallagher, & Gallo (1978) .
Cells were incubated at 37⁰C, 5% CO 2 in 1,640 RPMI medium with l-glutamine (20 nM), and 10% heat-inactivated foetal calf serum (FCS), Penicillin (100U/ml) and Streptomycin (100 μg/ml) (Biological Industries, Beit Haemek, Israel).
Clinical Relevance
Scientific rationale for the study: We have previously shown that Nuphar lutea semi-purified extracts have antiinflammatory, anti-cancer and anti-leishmanial activity, as well as the ability to modulate NF-kB activation, cytokine and iNOS production. The current study aimed to investi- Primary neutrophils were also obtained at the morning of the experiment from venous blood samples taken from patients according to their periodontal diagnosis (n = 3 for each group): periodontal healthy volunteers or young patients with classical symptoms of previously diagnosed and treated Localized Aggressive Periodontitis (LAP, molar-incisor type) according to the 1999 AAP criteria (1999)).
Blood was collected in standard heparin tubes, and neutrophils were isolated using Polymorphprep (Axis-shield, Oslo, Norway) according to manufacturer instructions.
The study was approved by the institutional Helsinki review board (Hadassah Medical Center approval Number HMO-0514-13.
| Bacteria
Aggregatibacter actinomycetemcomitans JP2 clone (clinical isolate, kindly provided by Prof. Gilad Bachrach, Hebrew University) was grown in a medium containing 0.5 g Yeast extract, 1.5 g Tryptone, 0.74 g D-glucose, 0.25 g NaCl, 0.075 g l-cysteine, 0.05 g Sodium thioglycolate and 4% NaHCO 3 (all purchased from Sigma-Aldrich, Rehovot, Israel) in double distilled water. JP2 purity was validated using TVSB selective culture (Slots, 1982) and PCR of bacterium` leukotoxin promoter region (Hoglund Aberg, Haubek, Kwamin, Johansson, & Claesson, 2014) . Bacteria were grown for 24 hr at 37⁰C in a 5% CO 2 chamber. Bacterial concentration was standardized by optical density according to Mattiello, Coelho, Martins, Mattiello, & Ferrao Junior (2011) . All experiments were done at multiplicity of infection 10.
| Nupharidine
Nupharidine (6,6′-Dihydroxythiobinupharidine) was purified from Nuphar lutea leaves and was purchased from Sigma-Aldrich/Merck (Cat. SMB00609). A stock solution in DMSO was made, and working dilutions were made in phosphate buffered saline (PBS). Solutions were kept at -20°C.
| Bacterial survival
Aa-JP2 were incubated for 1 hr with Nupharidine or vehicle control in the presence or absence of neutrophils (5 × 10 5 cells/well). After incubation supernatants were seeded on blood agar in 10-fold dilutions and incubated for 7 days at 37°C in a 5% CO 2 chamber, after which colony forming units (CFU) were calculated. 
| Neutrophils cytotoxicity
| Phagocytosis
| Reactive oxygen species (ROS)
Neutrophils ( 
| Neutrophil extracellular trap (NET) formation
| IL-1β, P50 and P65 intracellular staining
| Data analysis
All experiments were performed in triplicates and were repeated at least three times. The data were analysed using a statistical software package (SigmaStat; Jandel Scientific, San Rafael, CA, USA). Oneway repeated measure analysis of variance (RM ANOVA) was applied to test the significance of the differences between the treated groups. If the results were significant, inter-group differences were tested for significance using Student's t test and the Bonferroni correction for multiple testing. Further experiments were undertaken using the lower Nupharidine concentration that demonstrated effectiveness (12.5 μg/ml).
F I G U R E 1 cytotoxic effect of Nupharidine on JP2 and neutrophils. (a) Nupharidine (12.5 or 25 μg/ml) cytotoxicity against HL-60 derived neutrophils. FACS derived dot plots represent apoptosis staining (annexin v) and necrosis, staining with propidium iodine (PI). Red squares highlight the percentage of neutrophils positive for apoptosis and necrosis. (b) JP2 survival after incubation with neutrophils treated with Nupharidine or vehicle. HL-60 derived neutrophils were incubated with JP2 (MOI 10) and with Nupharidine (12.5 μg/ml or 25 μg/ml) or vehicle. Following incubation, supernatants were seeded on blood agar plate for CFU evaluation. * indicates statistical significance (P ≤ 0.05)
| Direct antibacterial effect of Nupharidine on JP2 viability
We examined the antibacterial effect of Nupharidine by incubating Aa-JP2 with Nupharidine (12.5 μg/ml) or vehicle. Live bacteria were determined by CFU analysis. The results showed that treatment with Nupharidine had no direct bactericidal activity on Aa-JP2 under the conditions tested (data not shown).
| Nupharidine`s effects on HL-60 derived neutrophils' killing mechanisms
Since Nupharidine did not show direct bactericidal properties against Aa-JP2, the most obvious supposition is that the enhanced bacterial killing in the presence of neutrophils is mediated by boosting neutrophil functions. Therefore, subsequent experiments focused on neutrophil effector functions-phagocytosis, reactive oxygen production (ROS) and generation of extracellular traps.
| Phagocytosis
Neutrophils engulf Aa-JP2 in their phagosome following Nupharidine treatment, portraying amplification of Aa-JP2 phagocytosis in the presence of Nupharidine compared with vehicle control (Figure 2a ).
Quantification of phagocytic cells revealed a significant increase
after incubation with Nupharidine, and 71.2% of cells engulfed Aa-JP2 after Nupharidine treatment in comparison to only 19.8% of controls (P = 0.002, Figure 2b) . However, the amount of engulfed bacteria per cell (measured as geometric mean florescence) was not significantly different between groups (Figure 2c ).
| Reactive oxygen production (ROS)
Total ROS (intracellular and extracellular) was found to be mildly elevated in the Nupharidine exposed neutrophils with Aa-JP2 (P < 0.001, Figure 3a) . Interestingly, analysis of intracellular ROS indicated that Nupharidine significantly augments internal ROS compared with controls (P = 0.038, Figure 3b ). 
F I G U R E 2
| Neutrophil extracellular traps
NET production was also significantly higher in the Nupharidine group vs. control (P < 0.001, Figure 4 ).
| Nupharidine effect on primary neutrophils from diseased and healthy subjects
In order to confirm the results with HL-60 derived neutrophils, we also performed experiments on primary human neutrophils obtained from peripheral blood of LAP-patients and periodontally healthy subjects, as described in the methods section. We exposed the cells to Aa-JP2 with or without the presence of Nupharidine.
Decreased bacterial survival and increased ROS production was observed in both primary cell sources after incubation with Nupharidine ( Figure 5 ) compared to neutrophils without Nupharidine. The cells from diseased patients were more responsive to Nupharidine treatment than those derived from healthy volunteers (Figure 5a ). These results were similar to those obtained with HL-60 derived cells.
| Enhancement of priming markers expression in HL-60 derived neutrophils by Nupharidine
The above results indicate that Nupharidine enhanced neutrophil effector cell functions (phagocytosis, ROS and NETosis), suggesting priming-like agent properties of Nupharidine. Therefore, expression of specific markers of neutrophil priming: iCAM and Dectin-2, as well as intracellular expression of IL-1β were tested (Yao et al., 2015) .
| Surface antigens
Treatment with Nupharidine significantly augmented the expression of outer membrane iCAM and Dectin-2 compared with vehicle control samples (Figure 6 ). Quantitative analysis of iCAM and Dectin-2 expression was significantly greater in the Nupharidine group compared with controls ( Figure 6 ).
| Cytokine production
Neutrophils treated with Nupharidine showed increased expression of IL-1β ( Figure 6 ). Control neutrophils (vehicle) also expressed IL-1β, but to lesser extent than their level in the test group ( Figure 6 ).
Quantitative analysis of IL-1β revealed a statistically significant difference between Nupharidine and control ( Figure 6 ). In the current study, we found that Nupharidine had no direct antibacterial effect on Aa-JP2. Nuphar Lutea extracts were found to have a direct leishmanicidal effect on Leishmania major (El-On et al.,
| D ISCUSS I ON
2009
) and an indirect effect through the activation of macrophages (Ozer et al., 2010) . In another study, Turker and Karakas (2009) found an antibacterial effect of N. Lutea extracts on several bacterial strains isolated from fish (Turker & Karakas, 2009 ) and Okamura et al. (2015) reported similar results against multidrug-resistant F I G U R E 3 Nupharidine effect on ROS in neutrophils. HL-60-derived neutrophils were incubated with unlabelled JP2 (MOI 10) with Nupharidine (12.5 μg/ml) or vehicle. ROS was measured by 7′-dichlorofluorescein diacetate assay as total values (using florescent plate reader, or as internal ROS using flow cytometry. bacteria (Okamura et al., 2015) . These results are in line with the fact that Nupharidine has a selective antimicrobial effect on certain micro-organisms while other microbes may be resistant to its effect (Okamura et al., 2015; Turker & Karakas, 2009 ). In the light of the absence of a direct effect of Nupharidine on JP2 viability, the bacterial clearance observed with Nupharidine and neutrophils infected with JP2, stems from an augmented ability of neutrophils to kill this pathogen. Still, one cannot exclude the possibility that Nupharidine may impact Aa-JP2 leukotoxicity, which in turn affects the interaction between the pathogen and neutrophils. Indeed, Nupharidine may affect Aa-JP2 toxicity by neutralization of JP2 leukotoxicity, similar to serum neutralization (Tsai et al., 1981) .
Subsequent data revealed a significant increase in all tested neu- Taken together, the results regarding ROS (with significant elevation in intracellular ROS) and phagocytosis, leads to the conclusion that Nupharidine enhances the clearance of Aa-JP2 by phagocytosis and its killing via intracellular ROS. These results were confirmed using primary neutrophils derived from healthy volunteers and periodontitis patients. ROS excess, which causes oxidative stress, can result in cell damage and pathologies such as atherosclerosis, F I G U R E 4 Nupharidine effect on NETosis. HL-60-derived neutrophils were incubated with unlabelled JP2 (MOI 10) with Nupharidine (12.5 μg/ml) or vehicle. Membrane-bound Extracellular DNA (NETosis) was quantified using MNase and SYTOX staining.
Results are expressed as mean and SD of arbitrary florescent units (AFU). * Indicates statistical significance (P ≤ 0.05)
The effect of Nupharidine on primary human neutrophils. Primary neutrophils were isolated from periodontally healthy and aggressive periodontitis subjects. Neutrophils were infected with JP2 (MOI 10) and in the presence of Nupharidine (12.5 μg/ml) or vehicle. diabetes, cancer, neurodegeneration and ageing (Ray, Huang, & Tsuji, 2012) . Furthermore, it has a clearly defined and substantial role in periodontal tissue destruction and periodontitis (Chapple, 1997) as ROS causes de-polymerization of hyaluronic acid and to a lesser extent proteoglycan, which are both constituents of extracellular matrix in the periodontium (Bartold, Wiebkin, & Thonard, 1984 ). In the current research, we show that total ROS levels were slightly elevated but a more substantial difference was detected regarding internal ROS production. We conclude that the secretion of ROS extracellularly was only slightly elevated after Nupharidine treatment, suggesting an antioxidative effect of Nupharidine with minimal likely danger to surrounding tissues following its use in vivo.
Neutrophil extracellular traps play a role in the development of several autoimmune diseases: components of NETs were found to cause an autoimmune response in small vessel Vasculitis; In Systemic
Lupus Erythematosus (SLE), NETs are considered a possible source of autoantigens due to its co-occurence with impaired degradation by DNase 1 (Yang et al., 2016) ; NETs provide a scaffold and stimulus for platelet and red blood cell adhesion and aggregation to blood vessel walls and therefore promote thrombosis (Fuchs et al., 2010) ; A key factor in Rheumatoid Arthritis (RA) is an autoimmune response against citrullinated proteins. Citrullination of proteins is a part of NET formation and therefore link NETosis to RA (Spengler et al., 2015) ; NETs are also currently studied in correlation to tumour formation, sepsis and their amplification in diabetic patients (Yang et al., 2016) . On the other hand, it may increase neutrophil anti- The response of diseased patients` primary neutrophils versus periodontally healthy neutrophils without Nupharidine reflects the well-established neutrophils hypo-function associated with aggressive periodontitis (DeNardin et al., 1990; Scott & Krauss, 2012; Shapira et al., 1991; Sigusch et al., 2001; Suzuki et al., 1984) . The beneficial effect of Nupharidine on the diseased patients' primary neutrophils may suggest that the Nupharidine priming of diseased patients` neutrophils recover neutrophils function to the functional levels of healthy neutrophils infected with Aa-JP2.
In accordance with the findings of Yao et al. (2015) , we found that neutrophils exhibit enhanced production of intracellular IL-1β
immediately after being treated with Nupharidine, and presented surface markers CD54/iCAM and Dectin-2 after treatment with Nupharidine. These results indicate that Nupharidine enhances Neutrophils' antimicrobial activity by priming neutrophils. This occurs naturally in sites of inflammation. In fact, the migration of neutrophils into tissues is enhanced by priming (Yao et al., 2015) .
Therefore, priming is likely to occur in an in vivo situation.
In conclusion, Nupharidine in vitro was found to have no direct bactericidal effect on A. actinomycetemcomitans JP2 clone, but it enhanced JP2 clearance by neutrophils. The enhanced clearance was F I G U R E 6 Neutrophils priming markers following exposure to Nupharidine. HL-60 neutrophils were incubated with Nupharidine (12.5 μg/ml) or vehicle. Following incubation, cells were stained for IL-1β production (internal staining) or iCAM and Dectin-2 (external staining). Analysis was done by FACS. Results are expressed as a histogram and compared with unstained cells (black histogram). Quantitative analysis of staining was done using geometric means values. * indicates statistical significance (P ≤ 0.05) associated with upregulation of neutrophil killing mechanisms, and priming of the neutrophils. Still, in vivo animal models as well as clinical trials are required to validate the results.
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